PS

Paul Kenneth Spearing

VU Vanderbilt University: 8 patents #84 of 1,609Top 6%
GL Glaxosmithkline: 5 patents #55 of 646Top 9%
SL Smithkline Beecham Limited: 1 patents #893 of 1,624Top 55%
📍 Nashville, TN: #94 of 2,243 inventorsTop 5%
🗺 Tennessee: #1,130 of 20,272 inventorsTop 6%
Overall (All Time): #307,614 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
12291521 Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Colleen M. Niswender, Rory A. Capstick +1 more 2025-05-06
11427573 Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Colleen M. Niswender, Rory A. Capstick +1 more 2022-08-30
11319304 Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Colleen M. Niswender, Rory A. Capstick +1 more 2022-05-03
11142532 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 Craig W. Lindsley, P. Jeffrey Conn, Darren W. Engers, Sean R. Bollinger, James C. Tarr +3 more 2021-10-12
10961253 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 Craig W. Lindsley, Darren W. Engers, P. Jeffrey Conn, Katrina A. Bollinger, Rory A. Capstick +1 more 2021-03-30
10927126 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 Craig W. Lindsley, P. Jeffrey Conn, Darren W. Engers, Alison R. Gregro, Kayla J. Temple +2 more 2021-02-23
10508105 Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Colleen M. Niswender, Rory A. Capstick +1 more 2019-12-17
10239887 Positive allosteric modulators of the muscarinic acetylcholine receptor M4 Craig W. Lindsley, P. Jeffrey Conn, Darren W. Engers, Sean R. Bollinger, James C. Tarr +3 more 2019-03-26
8822518 Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction David John Cowan, Andrew Lamont Larkin, Cunyu Zhang, David Lee Musso, Gary Martin Green +3 more 2014-09-02
8633175 Compounds as antagonists or inverse agonists at opioid receptors David John Cowan, Andrew Lamont Larkin, Cunyu Zhang, David Lee Musso, Gary Martin Green +3 more 2014-01-21
8158665 Farnesoid X receptor agonists Richard D. Caldwell, David Norman Deaton, Robert Blount McFadyen, Frank Navas, III 2012-04-17
7960552 Farnesoid X receptor agonists Jonathan York Bass, III, Justin Andrew Caravella, David Norman Deaton, Robert Blount McFadyen, Frank Navas, III 2011-06-14
7705028 Farnesoid X receptor agonists Richard D. Caldwell, David Norman Deaton, Robert Blout McFayden, Frank Navas, III 2010-04-27
6943162 Piperazinyltriazines as estrogen receptor modulators Ronnie Lee Hale, Brad Henke, Millard Hurst Lambert, III, Amy T. Lu, Philip Stewart Turnbull 2005-09-13
5922889 Synthesis of isochromans and their derivatives Horace G. Cutler, George Majetich, Xinrong Tian 1999-07-13